Expression of RANK-ligand in prostate cancer cell lines

Author： Penno Hendrik   Nilsson Olle   Brandstrom Helena   Winqvist Ola   Ljunggren Osten  

Publisher： Informa Healthcare

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.69, Iss.1, 2009-02, pp. : 151-155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epigenetics-related genes in prostate cancer: expression profile in prostate cancer tissues, androgen-sensitive and -insensitive cell lines

By          

International Journal of Molecular Medicine, Vol. 31, Iss. 1, 2013-01 ,pp. : 21-25

Spandidos Publications

Access to resources Recommend Favorite

Differential expression of ETS family members in prostate cancer tissues and androgen-sensitive and insensitive prostate cancer cell lines

By          

International Journal of Molecular Medicine, Vol. 28, Iss. 1, 2011-01 ,pp. : 89-93

Spandidos Publications

Access to resources Recommend Favorite

γ‐oryzanol reduces caveolin‐1 and PCGEM1 expression, markers of aggressiveness in prostate cancer cell lines

By  

THE PROSTATE, Vol. 75, Iss. 8, 2015-06 ,pp. : 783-797

John Wiley & Sons Inc

Access to resources Recommend Favorite

Paclitaxel Treatment of Breast Cancer Cell Lines Modulates Fas/Fas Ligand Expression and Induces Apoptosis Which Can Be Inhibited through the CD40 Receptor

By  

Oncology, Vol. 66, Iss. 2, 2004-05 ,pp. : 101-111

Karger

Access to resources Recommend Favorite

Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping

By  

Cytogenetic and Genome Research, Vol. 87, Iss. 3-4, 2000-02 ,pp. : 225-232

Karger

Access to resources Recommend Favorite